Related Experiment Videos
Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction.
D J Cox1, L A Gonder-Frederick, B P Kovatchev
1Behavioral Medicine Center, University of Virginia Health System, Charlottesville 22908, USA. djc4f@virginia.edu
Diabetes Care
|June 27, 2000
Summary
Driving impairment occurs at mild hypoglycemia, but people with diabetes delay treatment. Corrective actions are delayed until severe hypoglycemia, increasing risks while driving.
Area of Science:
- Neuroscience
- Endocrinology
- Diabetes Management
Background:
- Hypoglycemia, or low blood glucose, significantly impairs cognitive-motor functions essential for driving.
- Individuals with type 1 diabetes often experience impaired driving performance during hypoglycemic events.
Purpose of the Study:
- To determine the blood glucose (BG) thresholds for driving impairment, detection of impairment, and initiation of corrective actions.
- To investigate the underlying mechanisms of these three issues during hypoglycemia.
Main Methods:
- 37 adults with type 1 diabetes completed a driving simulator study under euglycemia and progressive hypoglycemia.
- Driving performance, electroencephalogram (EEG), BG levels, and symptom perception were monitored continuously.
- Corrective behaviors, such as consuming a sugary drink or stopping driving, were recorded.
Main Results:
- Driving performance was significantly impaired across all tested hypoglycemic BG ranges.
- Subjects were aware of their impaired driving but delayed corrective actions until BG levels dropped below 2.8 mmol/l.
- Driving impairment correlated with neurogenic symptoms and increased theta-wave activity; awareness of impairment linked to neuroglycopenic symptoms and increased beta-wave activity.
Conclusions:
- Driving ability is compromised at mild hypoglycemia, yet a significant delay in corrective action was observed.
- Delayed treatment exacerbates neuroglycopenia, hindering corrective behaviors.
- Recommendations include immediate self-treatment for suspected low BG or driving impairment and avoiding driving with BG between 5.0-4.0 mmol/l without prophylactic measures.